Evidence map›Paper›PMID 28894986›Full record

ArticleAIDS and behavior2018

Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.

Renee Heffron, Kerry Thomson, Connie Celum, Jessica Haberer, Kenneth Ngure, Nelly Mugo, Elizabeth Bukusi, Elly Katabira, Josephine Odoyo, Nulu Bulya and 4 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. "AIDS care · 2026
    Article
  3. CA Inhibitor 1 Treatment Does Not Affect Estrous Cyclicity in Mice.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Renee HeffronDepartment of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, USA. rheffron@uw.edu.ORCID http://orcid.org/0000-0001-6039-0352
Kerry ThomsonDepartment of Epidemiology, University of Washington, Seattle, USA.
Connie CelumDepartment of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, USA.
Jessica HabererMassachusetts General Hospital and Harvard Medical School, Boston, USA.
Kenneth NgureDepartment of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, USA.
Nelly MugoDepartment of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, USA.
Elizabeth BukusiDepartment of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, USA.
Elly KatabiraInfectious Disease Institute, Makerere University, Kampala, Uganda.
Josephine OdoyoCentre for Microbiology Research, Kenya Medical Research Institute, Nairobi, Kenya.
Nulu BulyaInfectious Disease Institute, Makerere University, Kampala, Uganda.
Stephen AsiimweKabwohe Clinical Research Center, Kabwohe, Uganda.
Edna TindimwebwaKabwohe Clinical Research Center, Kabwohe, Uganda.
Jared M BaetenDepartment of Global Health, University of Washington, 325 Ninth Avenue, Box 359927, Seattle, USA.
Partners Demonstration Project Team
University of Washington · USHarvard University · USJoint Clinical Research Centre · UGKenya Medical Research Institute · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Optimizing Antiretroviral-Based HIV Prevention for HIV Serodiscordant CouplesR01MH095507 · NIMH · UNIVERSITY OF WASHINGTON · PI BAETEN, JARED · 2011 to 2020
$6.1M
Antiretroviral periconception HIV prevention for HIV discordant couplesR00HD076679 · NICHD · UNIVERSITY OF WASHINGTON · PI HEFFRON, RENEE A. · 2015 to 2017
$742k
Bill and Melinda Gates Foundation (US) OPP1056051Eunice Kennedy Shriver National Institute of Child Health and Human Development (US) R00HD076679National Institute of Mental Health R01MH095507NIAID NIH HHS P30 AI027757NICHD NIH HHS R00 HD076679NIMH NIH HHS R01 MH095507United States Agency for International Development (US) AID-OAA-A-12-00023
6 · The paper itself

Abstract

African HIV serodiscordant couples often desire pregnancy, despite sexual HIV transmission risk during pregnancy attempts. Pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) reduce HIV risk and can be leveraged for safer conception but how well these strategies are used for safer conception is not known. We conducted an open-label demonstration project of the integrated delivery of PrEP and ART among 1013 HIV serodiscordant couples from Kenya and Uganda followed quarterly for 2 years. We evaluated fertility intentions, pregnancy incidence, the use of PrEP and ART during peri-conception, and peri-conception HIV incidence. At enrollment, 80% of couples indicated a desire for more children. Pregnancy incidence rates were 18.5 and 18.7 per 100 person years among HIV-uninfected and HIV-infected women, and higher among women who recently reported fertility intention (adjusted odds ratio 3.43, 95% CI 2.38-4.93) in multivariable GEE models. During the 6 months preceding pregnancy, 82.9% of couples used PrEP or ART and there were no HIV seroconversions. In this cohort with high pregnancy rates, integrated PrEP and ART was readily used by HIV serodiscordant couples, including during peri-conception periods. Widespread scale-up of safer conception counseling and services is warranted to respond to strong desires for pregnancy among HIV-affected men and women.

Indexed as

FertilizationHIV SeronegativityIntentionPre-Exposure ProphylaxisAdultAnti-HIV AgentsBlack PeopleChildFamily CharacteristicsFemaleFertilityHeterosexualityHIV InfectionsHIV SeropositivityHumansKenyaAnti-HIV AgentsAfricaARTDiscordant couplesPregnancyPrEPSafer conception

Identifiers

PMID28894986
PMCPMC5845763
OpenAlexW2754239831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.